BirchBioMed
ON - TorontoBiotechnology
Focus: BirchBioMed is a Toronto-based biotechnology company focused on antifibrogenic molecule development for wound healing and scar indications. The company appears to be in early-stage development with minimal publicly available operational scale data.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About BirchBioMed
AI assessmentNot HiringNo open roles listed right now. Follow BirchBioMed to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Vehicle Cream Base Emulsion Moisturizer + Petrolatum
Wound HealClinical Trials (1)
NCT04169438Pilot Study Investigating a Restorative Wound Care Cream Together With Petrolatum on Surgical Excisions
N/AHelp build intelligence for BirchBioMed
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.